AIM: To clarify the clinical significance of small,dense LDL (sLDL) in the metabolic syndrome associated with type 2 diabetes. METHODS: One hundred and ten healthy non-diabetic and non-metabolic syndrome subjects (58 male/52 female), 77 non-metabolic diabetic subjects (62/15), 58 non-diabetic metabolic subjects (25/33), and 46 metabolic diabetic subjects (29/17) were enrolled in this study. RESULTS: The subjects with metabolic syndrome (both with and without type 2 diabetes) had significantly higher fasting blood glucose, total-cholesterol (C), LDL-C, triglyceride, sLDL-C and hs-CRP levels than non-metabolic and non-diabetic subjects. HDL-C levels were significantly decreased in the former compared to the latter. Among the metabolic syndrome subjects, those with type 2 diabetes had significantly higher fasting blood glucose, systolic blood pressure and hs-CRP values than those without diabetes. sLDL-C, LDL-C and hs-CRP were the highest and HDL-C was lowest in the metabolic syndrome with diabetes group. A multiple regression analysis revealed the most significant determinant of sLDL-C to be LDL-C, followed by HDL-C, total-C, metabolic syndrome, type 2 diabetes mellitus, and triglyceride. CONCLUSION: Metabolic syndrome is a significant determinant of the plasma sLDL-C level. Hs-CRP was the highest in the metabolic syndrome patients with type 2 diabetes. Therefore, type 2 diabetes may further increase the risk of coronary artery disease in the metabolic syndrome subjects through cardiovascular inflammation.
AIM: To clarify the clinical significance of small,dense LDL (sLDL) in the metabolic syndrome associated with type 2 diabetes. METHODS: One hundred and ten healthy non-diabetic and non-metabolic syndrome subjects (58 male/52 female), 77 non-metabolic diabetic subjects (62/15), 58 non-diabetic metabolic subjects (25/33), and 46 metabolic diabetic subjects (29/17) were enrolled in this study. RESULTS: The subjects with metabolic syndrome (both with and without type 2 diabetes) had significantly higher fasting blood glucose, total-cholesterol (C), LDL-C, triglyceride, sLDL-C and hs-CRP levels than non-metabolic and non-diabetic subjects. HDL-C levels were significantly decreased in the former compared to the latter. Among the metabolic syndrome subjects, those with type 2 diabetes had significantly higher fasting blood glucose, systolic blood pressure and hs-CRP values than those without diabetes. sLDL-C, LDL-C and hs-CRP were the highest and HDL-C was lowest in the metabolic syndrome with diabetes group. A multiple regression analysis revealed the most significant determinant of sLDL-C to be LDL-C, followed by HDL-C, total-C, metabolic syndrome, type 2 diabetes mellitus, and triglyceride. CONCLUSION:Metabolic syndrome is a significant determinant of the plasma sLDL-C level. Hs-CRP was the highest in the metabolic syndromepatients with type 2 diabetes. Therefore, type 2 diabetes may further increase the risk of coronary artery disease in the metabolic syndrome subjects through cardiovascular inflammation.
Authors: Paula Tighe; Garry Duthie; Julie Brittenden; Nicholas Vaughan; William Mutch; William G Simpson; Susan Duthie; Graham W Horgan; Frank Thies Journal: PLoS One Date: 2013-08-05 Impact factor: 3.240
Authors: Irene Vinagre; José Luis Sánchez-Quesada; Juan Sánchez-Hernández; David Santos; Jordi Ordoñez-Llanos; Alberto De Leiva; Antonio Pérez Journal: Cardiovasc Diabetol Date: 2014-02-04 Impact factor: 9.951
Authors: Vinicius Pacheco Garcia; Helena Naly Miguens Rocha; Allan Robson Kluser Sales; Natália Galito Rocha; Antonio Claudio Lucas da Nóbrega Journal: Arq Bras Cardiol Date: 2016-03 Impact factor: 2.000
Authors: Nivedita Pavithran; Harish Kumar; Arun Somasekharan Menon; Gopala Krishna Pillai; Karimassery Ramaiyer Sundaram; Omorogieva Ojo Journal: Int J Environ Res Public Health Date: 2020-08-27 Impact factor: 3.390